Table 4.
Histologic parameter | Treated group (n=218) | Control group (n=65) | P value |
---|---|---|---|
Fibrosis and atrophy | <0.001 | ||
Absent | 0 (0%) | 12 (18.5%) | |
Mild | 10 (4.6%) | 29 (44.6%) | |
Moderate | 149 (68.3%) | 18 (27.7%) | |
Severe | 59 (27.1%) | 6 (9.2%) | |
Islet cell aggregation | <0.001 | ||
Present | 79 (36.2%) | 5 (7.7%) | |
Absent | 139 (63.8%) | 60 (92.3%) | |
Inflammation | 0.02 | ||
Grade 0 | 103 (47.3%) | 23 (35.4%) | |
Grade 1 | 86 (39.4%) | 21 (32.3%) | |
Grade 2 | 29 (13.3%) | 21 (32.3%) | |
Neuroma-like nerve proliferation | 0.005 | ||
Present | 34 (15.6%) | 2 (3.1%) | |
Absent | 184 (84.4%) | 63 (96.9%) |